Description
Semaglutide is a GLP-1 analogue used as an antidiabetic drug as a weekly subcutaneous injection. It is marketed under the name Ozempic in the form of pre-filled syringes containing four doses, each of 0,25 mg, or 0,50 mg, or 1 mg.
You must be connected to leave a review.
Reviews
There are no reviews yet.